Technology & Software Global On demand · 24-48h

Global Laboratory Automation Vision System Market Strategic Research Report

Name: Global Laboratory Automation Vision System Market Strategic Research Report
Brand: Market Research Reports, Inc.
Price: 3500 USD
Availability: PreOrder

Global Laboratory Automation Vision System Market Strategic …

$3,500 USD

Strategic Research Report

Global Laboratory Automation Vision System Market

$6.07B2025

14.8%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: High-Throughput Screening (HTS) Imaging Systems, Automated Microscopy & Digital Pathology Systems, Liquid Handling + Vision Integrated Platforms, Genomics & Sequencing Automation Systems, Clinical Diagnostic Automation Systems, Microplate Reading & Imaging Systems, Cell Culture & Live-Cell Imaging Systems

By Application: Pharmaceutical, Hospitals & Clinical

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer, Roche Diagnostics, Siemens Healthineers, BD (Becton Dickinson), Sartorius, Tecan Group, Hamilton Company, Bio-Rad Laboratories, Bruker Corporation, GE Healthcare Life Sciences, Eppendorf SE, Olympus Corporation, Mindray, Autobio Diagnostics

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2025 · forecast to 2032

Length: 125 pages

Market size 2025

$6.07B

Billion USD

Forecast CAGR

14.8%

2025-2032

Forecast 2032

$16B

Projected

リージョン

Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Laboratory Automation Vision System market size is predicted to grow from US$ 6,065 million in 2025 to US$ 15,898 million in 2032; it is expected to grow at a CAGR of 14.8% from 2026 to 2032.

A Laboratory Automation Vision System is an AI-driven imaging and analysis solution designed to automate visual inspection, identification, measurement, and classification tasks in laboratory environments. It integrates high-resolution cameras, microscopy imaging systems, computer vision algorithms, robotics, and laboratory information management systems (LIMS) to enable automated handling and analysis of biological, chemical, and medical samples with minimal human intervention.

Global key Laboratory Automation Vision System players cover Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer, Roche Diagnostics, etc.

This report presents a comprehensive overview of the global Laboratory Automation Vision System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

High-Throughput Screening (HTS) Imaging Systems
Automated Microscopy & Digital Pathology Systems
Liquid Handling + Vision Integrated Platforms
Genomics & Sequencing Automation Systems
Clinical Diagnostic Automation Systems
Microplate Reading & Imaging Systems
Cell Culture & Live-Cell Imaging Systems

Segment by Technology

Brightfield Imaging Systems
Fluorescence Imaging Systems
Confocal Microscopy Systems
AI-Based Image Analysis Systems
Deep Learning–Driven Cell Recognition Systems
High-Content Imaging (HCI) Systems
Hyperspectral / Multispectral Imaging Systems

Segment by Workflow Stage

Sample Preparation & Handling
Imaging & Data Acquisition
Analysis & Interpretation
Storage & Archiving
Reporting & Laboratory Information Management

Segment by Application

Pharmaceutical
Hospitals & Clinical

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Laboratory Automation Vision System market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Pharmaceutical, Hospitals & Clinical evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Laboratory Automation Vision System Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports

Market size CAGR 14.8%

Regional growth momentum

Market share by segment

Key metrics

Base value

$6.07B

2025

Forecast

$16B

2032

CAGR

14.8%

2025–2032

リージョン

global

Key companies

Thermo Fisher ScientificDanaher CorporationAgilent TechnologiesPerkinElmerRoche DiagnosticsSiemens HealthineersBD (Becton Dickinson)Sartorius

Segments covered in this report

By Type

High-Throughput Screening (HTS) Imaging SystemsAutomated Microscopy & Digital Pathology SystemsLiquid Handling + Vision Integrated PlatformsGenomics & Sequencing Automation SystemsClinical Diagnostic Automation SystemsMicroplate Reading & Imaging SystemsCell Culture & Live-Cell Imaging Systems

By Application

PharmaceuticalHospitals & Clinical

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 High-Throughput Screening (HTS) Imaging Systems
3.1.3 Automated Microscopy & Digital Pathology Systems
3.1.4 Liquid Handling + Vision Integrated Platforms
3.1.5 Genomics & Sequencing Automation Systems
3.1.6 Clinical Diagnostic Automation Systems
3.1.7 Microplate Reading & Imaging Systems
3.1.8 Cell Culture & Live-Cell Imaging Systems
3.1.9 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Pharmaceutical
4.1.3 Hospitals & Clinical
4.1.4 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 Thermo Fisher Scientific
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Danaher Corporation
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 Agilent Technologies
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 PerkinElmer
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 Roche Diagnostics
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 Siemens Healthineers
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 BD (Becton Dickinson)
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 Sartorius
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 Tecan Group
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 Hamilton Company
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Bio-Rad Laboratories
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 Bruker Corporation
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 GE Healthcare Life Sciences
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 Eppendorf SE
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)
8.15 Olympus Corporation
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2026–2032)
8.16 Mindray
8.16.1 Company Overview
8.16.2 Key Products & Segments
8.16.3 Financial Performance (2023–2025)
8.16.4 Business Strategy
8.16.5 SWOT Analysis
8.16.6 Strategic Implications (2026–2032)
8.17 Autobio Diagnostics
8.17.1 Company Overview
8.17.2 Key Products & Segments
8.17.3 Financial Performance (2023–2025)
8.17.4 Business Strategy
8.17.5 SWOT Analysis
8.17.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Laboratory Automation Vision System market size?

The global Laboratory Automation Vision System market is estimated at US$ 6.07 billion in 2025 (base year) and is projected to reach US$ 15.9 billion by 2032.

What growth rate is expected for the Laboratory Automation Vision System market through 2032?

The market is expected to grow at a CAGR of 14.8% from 2026 to 2032, expanding from US$ 6.07 billion in 2025 to US$ 15.9 billion in 2032, roughly 2.6 times its base-year value.

How is Laboratory Automation Vision System defined?

What are the main segments of the Laboratory Automation Vision System market by type?

By type, the market is segmented into High-Throughput Screening (HTS) Imaging Systems, Automated Microscopy & Digital Pathology Systems, Liquid Handling + Vision Integrated Platforms, Genomics & Sequencing Automation Systems, Clinical Diagnostic Automation Systems, Microplate Reading & Imaging Systems and Cell Culture & Live-Cell Imaging Systems.

Which applications drive demand in the Laboratory Automation Vision System market?

Key applications covered include Pharmaceutical and Hospitals & Clinical.

Who are the key players in the Laboratory Automation Vision System market?

Key players profiled include Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer, Roche Diagnostics, Siemens Healthineers, BD (Becton Dickinson) and Sartorius, among 17 companies covered in total.

Which regions and countries are covered for Laboratory Automation Vision System?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

What is driving growth in the Laboratory Automation Vision System market?

Who should buy the Laboratory Automation Vision System market report?

The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical and Hospitals & Clinical, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Laboratory Automation Vision System market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.